New Immuno-Regulating Drug

Integrating Chinese Technology with American Ideals

New Immuno-Regulating Drug
for Respiratory Infection & Bronchitic Infection

Introduction

About two-thirds of children patients suffer from respiratory infection and bronchitic asthma. Patients suffering from these diseases may have certain defects or disturbances in their immune system.But there are few drugs available to fully treat the cases if the improvement of immunity is considered.

Our Technology

We have developed a new well flavored, oral immuno regulating drug. An easy to take drug, it is more effective than other drugs of the same typeprepared from spleen extract, embryo lipopolysaccharide, or hydrosylate of nucleic acid. Our new drug has been approved for use in China.

Therapeutic Effects

good apetite and sleep

reduction in night perspiration

reduction in therapeutic period and the dosage of anti-infection or anti-asthma drugs

enhancement of resistance to disease

no significant side effects

This Solution acts as an immuno-suppressant in children with asthma conditions

Get More Information

TOP THREE RELATED SITES

Transdermal Therapeutic Patch
Pearl Powder
Anticlotting Enzyme

Go Back to The Guide to Technologies

We are proud to be affiliated with:

Chinese Academy
of Science
&
City College of New York
We have access
to 50,000 top
scientists & A Vast
Network of
Business Contacts
throughout China

Contact CTC:

	China-America Technology Corp.		TEL: +1-212-650-5606
	Marshak Science Bldg., Rm. J423		FAX: +1-212-650-5608
	138th St. at Convent Ave.			
	New York, NY 10031

ctc@chinatech.com